CAPR
NASDAQ · Biotechnology
Capricor Therapeutics Inc
$29.83
+0.23 (+0.78%)
Open$29.87
Previous Close$29.60
Day High$30.02
Day Low$29.64
52W High$40.37
52W Low$4.30
Volume—
Avg Volume1.19M
Market Cap1.64B
P/E Ratio—
EPS$-2.31
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+109.3% upside
Current
$29.83
$29.83
Target
$62.44
$62.44
$34.96
$62.44 avg
$82.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 30.52M | 187.20M | 168.99M |
| Net Income | -55,455,340 | 36.18M | 32.84M |
| Profit Margin | -181.7% | 19.3% | 19.4% |
| EBITDA | -56,521,974 | 59.64M | 51.36M |
| Free Cash Flow | — | 19.67M | 27.43M |
| Rev Growth | +352.7% | +21.4% | +1.7% |
| Debt/Equity | 0.02 | 1.29 | 1.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |